Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

1.23
Delayed Data
As of May 04
 -0.13 / -9.56%
Today’s Change
1.22
Today|||52-Week Range
12.55
-61.56%
Year-to-Date
No recent news for Northwest Biotherapeutics Inc.

Today’s Trading

Previous close1.36
Today’s open1.40
Day’s range1.22 - 1.40
Volume846,378
Average volume (3 months)486,568
Market cap$136.3M
Dividend yield--
Data as of 05/04/2016

Growth & Valuation

Earnings growth (last year)+35.37%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+19.60%
P/E ratioNM
Price/Sales143.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AFMDAffimed NV-0.25-6.49%
OCXOncoCyte Corp-0.27-5.10%
EIGREiger BioPharmaceuti...-0.14-0.70%
ADMPAdamis Pharmaceutica...+0.05+0.56%
Data as of 05/04/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$1.7M
Annual profit (last year)-$114.7M
Net profit margin-6,598.10%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer &
Secretary
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts

Partner Offers

Search for Jobs